China SXT Pharmaceuticals is a holding company. Through its subsidiaries, Co. focuses on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces (TCMP). Co. has two types of Advanced TCMP: Directly-Oral TCMP and After-Soaking-Oral TCMP products. Co. produces Fine TCMP products for drug stores and hospitals. Co. manufactures Regular TCMP products for the treatment of various diseases or serving as dietary supplements. Co. has a product-developed portfolio of 19 Advanced TCMP products among which Advanced TCMP products have been commercialized, Fine TCMP products, and Regular TCMP products that address a variety of diseases and medical indications. The SXTC stock yearly return is shown above.
The yearly return on the SXTC stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SXTC annual return calculation with any dividends reinvested as applicable (on ex-dates).
|